Description

Glimisave MV 2 Tablet is a medicine used in the treatment of type 2 diabetes. It contains a combination of Glimepiride, Metformin, and Voglibose. Glimepiride helps to lower blood sugar levels by stimulating the pancreas to release insulin. Metformin works by decreasing liver glucose production and increasing the body’s response to insulin. Voglibose reduces post-meal blood sugar levels by delaying the absorption of glucose in the intestine. Glimisave MV 2 Tablet is prescribed to control blood sugar levels in individuals with type 2 diabetes. It aids in the management of hyperglycemia when a healthy diet and physical exercise alone are insufficient. Regular monitoring of blood sugar levels is recommended to assess the effectiveness of the treatment. Glimisave MV 2 Tablet is an effective solution for individuals with type 2 diabetes seeking to manage their condition and maintain stable blood sugar levels.

Additional information